119 followers
Phase 1b randomized, double-blind study of namilumab, an anti-granulocyte macrophage colony-stimulating factor... https://t.co/1buZq3CsOX
Phase 1b randomized, double-blind study of namilumab, an anti-granulocyte macrophage colony-stimulating factor... https://t.co/1buZq3CsOX